Global Cancer Biopsy Market Research Report 2025(Status and Outlook)
Report Overview
The cancer biopsy market encompasses diagnostic procedures involving the extraction and analysis of tissue or fluid samples to detect and characterize cancerous cells, aiding in accurate diagnosis, staging, and personalized treatment planning. This market includes various biopsy techniques such as needle biopsies (fine-needle aspiration and core needle biopsies), surgical biopsies (incisional and excisional), and liquid biopsies, which analyze circulating tumor DNA (ctDNA) or other biomarkers in blood. Advances in minimally invasive techniques, molecular diagnostics, and genomic profiling have expanded the market, driven by rising cancer incidence, growing demand for early and precise detection, and the increasing adoption of targeted therapies. Key segments include breast, lung, prostate, and colorectal cancers, with liquid biopsies gaining traction due to their non-invasive nature and potential for real-time monitoring. The market is also influenced by regulatory approvals, reimbursement policies, and investments in precision medicine, with major players focusing on innovation in biopsy technologies and companion diagnostics. Emerging economies are witnessing growth due to improving healthcare infrastructure and rising awareness, though high costs and procedural complexities remain challenges in certain regions.
The global Cancer Biopsy market size was estimated at USD 3103.91 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Biopsy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Biopsy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Biopsy market.
Global Cancer Biopsy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Qiagen N.V.
IlluminaInc.
ANGLE Plc
Myriad Genetics
HologicInc.
BioceptInc.
Thermo Fisher ScientificInc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAILInc.
Guardant Health
Exact Sciences Corporation
Freenome HoldingsInc.
Oncimmune
Chronix BiomedicalInc.
Personal Genome Diagnostics Inc.
Market Segmentation (by Type)
Tissue Biopsies
Liquid Biopsies
Others
Market Segmentation (by Application)
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Biopsy Market
Overview of the regional outlook of the Cancer Biopsy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Biopsy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The cancer biopsy market encompasses diagnostic procedures involving the extraction and analysis of tissue or fluid samples to detect and characterize cancerous cells, aiding in accurate diagnosis, staging, and personalized treatment planning. This market includes various biopsy techniques such as needle biopsies (fine-needle aspiration and core needle biopsies), surgical biopsies (incisional and excisional), and liquid biopsies, which analyze circulating tumor DNA (ctDNA) or other biomarkers in blood. Advances in minimally invasive techniques, molecular diagnostics, and genomic profiling have expanded the market, driven by rising cancer incidence, growing demand for early and precise detection, and the increasing adoption of targeted therapies. Key segments include breast, lung, prostate, and colorectal cancers, with liquid biopsies gaining traction due to their non-invasive nature and potential for real-time monitoring. The market is also influenced by regulatory approvals, reimbursement policies, and investments in precision medicine, with major players focusing on innovation in biopsy technologies and companion diagnostics. Emerging economies are witnessing growth due to improving healthcare infrastructure and rising awareness, though high costs and procedural complexities remain challenges in certain regions.
The global Cancer Biopsy market size was estimated at USD 3103.91 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Biopsy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Biopsy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Biopsy market.
Global Cancer Biopsy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Qiagen N.V.
IlluminaInc.
ANGLE Plc
Myriad Genetics
HologicInc.
BioceptInc.
Thermo Fisher ScientificInc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAILInc.
Guardant Health
Exact Sciences Corporation
Freenome HoldingsInc.
Oncimmune
Chronix BiomedicalInc.
Personal Genome Diagnostics Inc.
Market Segmentation (by Type)
Tissue Biopsies
Liquid Biopsies
Others
Market Segmentation (by Application)
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Biopsy Market
Overview of the regional outlook of the Cancer Biopsy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Biopsy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cancer Biopsy
1.2 Key Market Segments
1.2.1 Cancer Biopsy Segment by Type
1.2.2 Cancer Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Biopsy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cancer Biopsy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Biopsy Product Life Cycle
3.3 Global Cancer Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Cancer Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Biopsy Market Competitive Situation and Trends
3.8.1 Cancer Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cancer Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANCER BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Cancer Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Biopsy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cancer Biopsy Market
5.7 ESG Ratings of Leading Companies
6 CANCER BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Cancer Biopsy Market Size Market Share by Type (2020-2025)
6.4 Global Cancer Biopsy Price by Type (2020-2025)
7 CANCER BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Biopsy Market Sales by Application (2020-2025)
7.3 Global Cancer Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Biopsy Sales Growth Rate by Application (2020-2025)
8 CANCER BIOPSY MARKET SALES BY REGION
8.1 Global Cancer Biopsy Sales by Region
8.1.1 Global Cancer Biopsy Sales by Region
8.1.2 Global Cancer Biopsy Sales Market Share by Region
8.2 Global Cancer Biopsy Market Size by Region
8.2.1 Global Cancer Biopsy Market Size by Region
8.2.2 Global Cancer Biopsy Market Size Market Share by Region
8.3 North America
8.3.1 North America Cancer Biopsy Sales by Country
8.3.2 North America Cancer Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cancer Biopsy Sales by Country
8.4.2 Europe Cancer Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cancer Biopsy Sales by Region
8.5.2 Asia Pacific Cancer Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cancer Biopsy Sales by Country
8.6.2 South America Cancer Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cancer Biopsy Sales by Region
8.7.2 Middle East and Africa Cancer Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANCER BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Biopsy by Region(2020-2025)
9.2 Global Cancer Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Biopsy Production
9.4.1 North America Cancer Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Biopsy Production
9.5.1 Europe Cancer Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Biopsy Production (2020-2025)
9.6.1 Japan Cancer Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Biopsy Production (2020-2025)
9.7.1 China Cancer Biopsy Production Growth Rate (2020-2025)
9.7.2 China Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Qiagen N.V.
10.1.1 Qiagen N.V. Basic Information
10.1.2 Qiagen N.V. Cancer Biopsy Product Overview
10.1.3 Qiagen N.V. Cancer Biopsy Product Market Performance
10.1.4 Qiagen N.V. Business Overview
10.1.5 Qiagen N.V. SWOT Analysis
10.1.6 Qiagen N.V. Recent Developments
10.2 IlluminaInc.
10.2.1 IlluminaInc. Basic Information
10.2.2 IlluminaInc. Cancer Biopsy Product Overview
10.2.3 IlluminaInc. Cancer Biopsy Product Market Performance
10.2.4 IlluminaInc. Business Overview
10.2.5 IlluminaInc. SWOT Analysis
10.2.6 IlluminaInc. Recent Developments
10.3 ANGLE Plc
10.3.1 ANGLE Plc Basic Information
10.3.2 ANGLE Plc Cancer Biopsy Product Overview
10.3.3 ANGLE Plc Cancer Biopsy Product Market Performance
10.3.4 ANGLE Plc Business Overview
10.3.5 ANGLE Plc SWOT Analysis
10.3.6 ANGLE Plc Recent Developments
10.4 Myriad Genetics
10.4.1 Myriad Genetics Basic Information
10.4.2 Myriad Genetics Cancer Biopsy Product Overview
10.4.3 Myriad Genetics Cancer Biopsy Product Market Performance
10.4.4 Myriad Genetics Business Overview
10.4.5 Myriad Genetics Recent Developments
10.5 HologicInc.
10.5.1 HologicInc. Basic Information
10.5.2 HologicInc. Cancer Biopsy Product Overview
10.5.3 HologicInc. Cancer Biopsy Product Market Performance
10.5.4 HologicInc. Business Overview
10.5.5 HologicInc. Recent Developments
10.6 BioceptInc.
10.6.1 BioceptInc. Basic Information
10.6.2 BioceptInc. Cancer Biopsy Product Overview
10.6.3 BioceptInc. Cancer Biopsy Product Market Performance
10.6.4 BioceptInc. Business Overview
10.6.5 BioceptInc. Recent Developments
10.7 Thermo Fisher ScientificInc.
10.7.1 Thermo Fisher ScientificInc. Basic Information
10.7.2 Thermo Fisher ScientificInc. Cancer Biopsy Product Overview
10.7.3 Thermo Fisher ScientificInc. Cancer Biopsy Product Market Performance
10.7.4 Thermo Fisher ScientificInc. Business Overview
10.7.5 Thermo Fisher ScientificInc. Recent Developments
10.8 Danaher
10.8.1 Danaher Basic Information
10.8.2 Danaher Cancer Biopsy Product Overview
10.8.3 Danaher Cancer Biopsy Product Market Performance
10.8.4 Danaher Business Overview
10.8.5 Danaher Recent Developments
10.9 Lucence Diagnostics Pte. Ltd.
10.9.1 Lucence Diagnostics Pte. Ltd. Basic Information
10.9.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Overview
10.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Market Performance
10.9.4 Lucence Diagnostics Pte. Ltd. Business Overview
10.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments
10.10 GRAILInc.
10.10.1 GRAILInc. Basic Information
10.10.2 GRAILInc. Cancer Biopsy Product Overview
10.10.3 GRAILInc. Cancer Biopsy Product Market Performance
10.10.4 GRAILInc. Business Overview
10.10.5 GRAILInc. Recent Developments
10.11 Guardant Health
10.11.1 Guardant Health Basic Information
10.11.2 Guardant Health Cancer Biopsy Product Overview
10.11.3 Guardant Health Cancer Biopsy Product Market Performance
10.11.4 Guardant Health Business Overview
10.11.5 Guardant Health Recent Developments
10.12 Exact Sciences Corporation
10.12.1 Exact Sciences Corporation Basic Information
10.12.2 Exact Sciences Corporation Cancer Biopsy Product Overview
10.12.3 Exact Sciences Corporation Cancer Biopsy Product Market Performance
10.12.4 Exact Sciences Corporation Business Overview
10.12.5 Exact Sciences Corporation Recent Developments
10.13 Freenome HoldingsInc.
10.13.1 Freenome HoldingsInc. Basic Information
10.13.2 Freenome HoldingsInc. Cancer Biopsy Product Overview
10.13.3 Freenome HoldingsInc. Cancer Biopsy Product Market Performance
10.13.4 Freenome HoldingsInc. Business Overview
10.13.5 Freenome HoldingsInc. Recent Developments
10.14 Oncimmune
10.14.1 Oncimmune Basic Information
10.14.2 Oncimmune Cancer Biopsy Product Overview
10.14.3 Oncimmune Cancer Biopsy Product Market Performance
10.14.4 Oncimmune Business Overview
10.14.5 Oncimmune Recent Developments
10.15 Chronix BiomedicalInc.
10.15.1 Chronix BiomedicalInc. Basic Information
10.15.2 Chronix BiomedicalInc. Cancer Biopsy Product Overview
10.15.3 Chronix BiomedicalInc. Cancer Biopsy Product Market Performance
10.15.4 Chronix BiomedicalInc. Business Overview
10.15.5 Chronix BiomedicalInc. Recent Developments
10.16 Personal Genome Diagnostics Inc.
10.16.1 Personal Genome Diagnostics Inc. Basic Information
10.16.2 Personal Genome Diagnostics Inc. Cancer Biopsy Product Overview
10.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Product Market Performance
10.16.4 Personal Genome Diagnostics Inc. Business Overview
10.16.5 Personal Genome Diagnostics Inc. Recent Developments
11 CANCER BIOPSY MARKET FORECAST BY REGION
11.1 Global Cancer Biopsy Market Size Forecast
11.2 Global Cancer Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Biopsy Market Size Forecast by Region
11.2.4 South America Cancer Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cancer Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cancer Biopsy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cancer Biopsy by Type (2026-2033)
12.1.2 Global Cancer Biopsy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cancer Biopsy by Type (2026-2033)
12.2 Global Cancer Biopsy Market Forecast by Application (2026-2033)
12.2.1 Global Cancer Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Cancer Biopsy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cancer Biopsy
1.2 Key Market Segments
1.2.1 Cancer Biopsy Segment by Type
1.2.2 Cancer Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Biopsy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cancer Biopsy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Biopsy Product Life Cycle
3.3 Global Cancer Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Cancer Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Biopsy Market Competitive Situation and Trends
3.8.1 Cancer Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cancer Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANCER BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Cancer Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Biopsy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cancer Biopsy Market
5.7 ESG Ratings of Leading Companies
6 CANCER BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Cancer Biopsy Market Size Market Share by Type (2020-2025)
6.4 Global Cancer Biopsy Price by Type (2020-2025)
7 CANCER BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Biopsy Market Sales by Application (2020-2025)
7.3 Global Cancer Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Biopsy Sales Growth Rate by Application (2020-2025)
8 CANCER BIOPSY MARKET SALES BY REGION
8.1 Global Cancer Biopsy Sales by Region
8.1.1 Global Cancer Biopsy Sales by Region
8.1.2 Global Cancer Biopsy Sales Market Share by Region
8.2 Global Cancer Biopsy Market Size by Region
8.2.1 Global Cancer Biopsy Market Size by Region
8.2.2 Global Cancer Biopsy Market Size Market Share by Region
8.3 North America
8.3.1 North America Cancer Biopsy Sales by Country
8.3.2 North America Cancer Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cancer Biopsy Sales by Country
8.4.2 Europe Cancer Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cancer Biopsy Sales by Region
8.5.2 Asia Pacific Cancer Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cancer Biopsy Sales by Country
8.6.2 South America Cancer Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cancer Biopsy Sales by Region
8.7.2 Middle East and Africa Cancer Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANCER BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Biopsy by Region(2020-2025)
9.2 Global Cancer Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Biopsy Production
9.4.1 North America Cancer Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Biopsy Production
9.5.1 Europe Cancer Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Biopsy Production (2020-2025)
9.6.1 Japan Cancer Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Biopsy Production (2020-2025)
9.7.1 China Cancer Biopsy Production Growth Rate (2020-2025)
9.7.2 China Cancer Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Qiagen N.V.
10.1.1 Qiagen N.V. Basic Information
10.1.2 Qiagen N.V. Cancer Biopsy Product Overview
10.1.3 Qiagen N.V. Cancer Biopsy Product Market Performance
10.1.4 Qiagen N.V. Business Overview
10.1.5 Qiagen N.V. SWOT Analysis
10.1.6 Qiagen N.V. Recent Developments
10.2 IlluminaInc.
10.2.1 IlluminaInc. Basic Information
10.2.2 IlluminaInc. Cancer Biopsy Product Overview
10.2.3 IlluminaInc. Cancer Biopsy Product Market Performance
10.2.4 IlluminaInc. Business Overview
10.2.5 IlluminaInc. SWOT Analysis
10.2.6 IlluminaInc. Recent Developments
10.3 ANGLE Plc
10.3.1 ANGLE Plc Basic Information
10.3.2 ANGLE Plc Cancer Biopsy Product Overview
10.3.3 ANGLE Plc Cancer Biopsy Product Market Performance
10.3.4 ANGLE Plc Business Overview
10.3.5 ANGLE Plc SWOT Analysis
10.3.6 ANGLE Plc Recent Developments
10.4 Myriad Genetics
10.4.1 Myriad Genetics Basic Information
10.4.2 Myriad Genetics Cancer Biopsy Product Overview
10.4.3 Myriad Genetics Cancer Biopsy Product Market Performance
10.4.4 Myriad Genetics Business Overview
10.4.5 Myriad Genetics Recent Developments
10.5 HologicInc.
10.5.1 HologicInc. Basic Information
10.5.2 HologicInc. Cancer Biopsy Product Overview
10.5.3 HologicInc. Cancer Biopsy Product Market Performance
10.5.4 HologicInc. Business Overview
10.5.5 HologicInc. Recent Developments
10.6 BioceptInc.
10.6.1 BioceptInc. Basic Information
10.6.2 BioceptInc. Cancer Biopsy Product Overview
10.6.3 BioceptInc. Cancer Biopsy Product Market Performance
10.6.4 BioceptInc. Business Overview
10.6.5 BioceptInc. Recent Developments
10.7 Thermo Fisher ScientificInc.
10.7.1 Thermo Fisher ScientificInc. Basic Information
10.7.2 Thermo Fisher ScientificInc. Cancer Biopsy Product Overview
10.7.3 Thermo Fisher ScientificInc. Cancer Biopsy Product Market Performance
10.7.4 Thermo Fisher ScientificInc. Business Overview
10.7.5 Thermo Fisher ScientificInc. Recent Developments
10.8 Danaher
10.8.1 Danaher Basic Information
10.8.2 Danaher Cancer Biopsy Product Overview
10.8.3 Danaher Cancer Biopsy Product Market Performance
10.8.4 Danaher Business Overview
10.8.5 Danaher Recent Developments
10.9 Lucence Diagnostics Pte. Ltd.
10.9.1 Lucence Diagnostics Pte. Ltd. Basic Information
10.9.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Overview
10.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Market Performance
10.9.4 Lucence Diagnostics Pte. Ltd. Business Overview
10.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments
10.10 GRAILInc.
10.10.1 GRAILInc. Basic Information
10.10.2 GRAILInc. Cancer Biopsy Product Overview
10.10.3 GRAILInc. Cancer Biopsy Product Market Performance
10.10.4 GRAILInc. Business Overview
10.10.5 GRAILInc. Recent Developments
10.11 Guardant Health
10.11.1 Guardant Health Basic Information
10.11.2 Guardant Health Cancer Biopsy Product Overview
10.11.3 Guardant Health Cancer Biopsy Product Market Performance
10.11.4 Guardant Health Business Overview
10.11.5 Guardant Health Recent Developments
10.12 Exact Sciences Corporation
10.12.1 Exact Sciences Corporation Basic Information
10.12.2 Exact Sciences Corporation Cancer Biopsy Product Overview
10.12.3 Exact Sciences Corporation Cancer Biopsy Product Market Performance
10.12.4 Exact Sciences Corporation Business Overview
10.12.5 Exact Sciences Corporation Recent Developments
10.13 Freenome HoldingsInc.
10.13.1 Freenome HoldingsInc. Basic Information
10.13.2 Freenome HoldingsInc. Cancer Biopsy Product Overview
10.13.3 Freenome HoldingsInc. Cancer Biopsy Product Market Performance
10.13.4 Freenome HoldingsInc. Business Overview
10.13.5 Freenome HoldingsInc. Recent Developments
10.14 Oncimmune
10.14.1 Oncimmune Basic Information
10.14.2 Oncimmune Cancer Biopsy Product Overview
10.14.3 Oncimmune Cancer Biopsy Product Market Performance
10.14.4 Oncimmune Business Overview
10.14.5 Oncimmune Recent Developments
10.15 Chronix BiomedicalInc.
10.15.1 Chronix BiomedicalInc. Basic Information
10.15.2 Chronix BiomedicalInc. Cancer Biopsy Product Overview
10.15.3 Chronix BiomedicalInc. Cancer Biopsy Product Market Performance
10.15.4 Chronix BiomedicalInc. Business Overview
10.15.5 Chronix BiomedicalInc. Recent Developments
10.16 Personal Genome Diagnostics Inc.
10.16.1 Personal Genome Diagnostics Inc. Basic Information
10.16.2 Personal Genome Diagnostics Inc. Cancer Biopsy Product Overview
10.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Product Market Performance
10.16.4 Personal Genome Diagnostics Inc. Business Overview
10.16.5 Personal Genome Diagnostics Inc. Recent Developments
11 CANCER BIOPSY MARKET FORECAST BY REGION
11.1 Global Cancer Biopsy Market Size Forecast
11.2 Global Cancer Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Biopsy Market Size Forecast by Region
11.2.4 South America Cancer Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cancer Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cancer Biopsy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cancer Biopsy by Type (2026-2033)
12.1.2 Global Cancer Biopsy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cancer Biopsy by Type (2026-2033)
12.2 Global Cancer Biopsy Market Forecast by Application (2026-2033)
12.2.1 Global Cancer Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Cancer Biopsy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Cancer Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cancer Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cancer Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cancer Biopsy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2024)
Table 10. Global Market Cancer Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cancer Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cancer Biopsy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cancer Biopsy Sales by Type (K Units)
Table 26. Global Cancer Biopsy Market Size by Type (M USD)
Table 27. Global Cancer Biopsy Sales (K Units) by Type (2020-2025)
Table 28. Global Cancer Biopsy Sales Market Share by Type (2020-2025)
Table 29. Global Cancer Biopsy Market Size (M USD) by Type (2020-2025)
Table 30. Global Cancer Biopsy Market Size Share by Type (2020-2025)
Table 31. Global Cancer Biopsy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cancer Biopsy Sales (K Units) by Application
Table 33. Global Cancer Biopsy Market Size by Application
Table 34. Global Cancer Biopsy Sales by Application (2020-2025) & (K Units)
Table 35. Global Cancer Biopsy Sales Market Share by Application (2020-2025)
Table 36. Global Cancer Biopsy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cancer Biopsy Market Share by Application (2020-2025)
Table 38. Global Cancer Biopsy Sales Growth Rate by Application (2020-2025)
Table 39. Global Cancer Biopsy Sales by Region (2020-2025) & (K Units)
Table 40. Global Cancer Biopsy Sales Market Share by Region (2020-2025)
Table 41. Global Cancer Biopsy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cancer Biopsy Market Size Market Share by Region (2020-2025)
Table 43. North America Cancer Biopsy Sales by Country (2020-2025) & (K Units)
Table 44. North America Cancer Biopsy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cancer Biopsy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cancer Biopsy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cancer Biopsy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cancer Biopsy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cancer Biopsy Sales by Country (2020-2025) & (K Units)
Table 50. South America Cancer Biopsy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cancer Biopsy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cancer Biopsy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cancer Biopsy Production (K Units) by Region(2020-2025)
Table 54. Global Cancer Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cancer Biopsy Revenue Market Share by Region (2020-2025)
Table 56. Global Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Qiagen N.V. Basic Information
Table 62. Qiagen N.V. Cancer Biopsy Product Overview
Table 63. Qiagen N.V. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Qiagen N.V. Business Overview
Table 65. Qiagen N.V. SWOT Analysis
Table 66. Qiagen N.V. Recent Developments
Table 67. IlluminaInc. Basic Information
Table 68. IlluminaInc. Cancer Biopsy Product Overview
Table 69. IlluminaInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. IlluminaInc. Business Overview
Table 71. IlluminaInc. SWOT Analysis
Table 72. IlluminaInc. Recent Developments
Table 73. ANGLE Plc Basic Information
Table 74. ANGLE Plc Cancer Biopsy Product Overview
Table 75. ANGLE Plc Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. ANGLE Plc Business Overview
Table 77. ANGLE Plc SWOT Analysis
Table 78. ANGLE Plc Recent Developments
Table 79. Myriad Genetics Basic Information
Table 80. Myriad Genetics Cancer Biopsy Product Overview
Table 81. Myriad Genetics Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Myriad Genetics Business Overview
Table 83. Myriad Genetics Recent Developments
Table 84. HologicInc. Basic Information
Table 85. HologicInc. Cancer Biopsy Product Overview
Table 86. HologicInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. HologicInc. Business Overview
Table 88. HologicInc. Recent Developments
Table 89. BioceptInc. Basic Information
Table 90. BioceptInc. Cancer Biopsy Product Overview
Table 91. BioceptInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioceptInc. Business Overview
Table 93. BioceptInc. Recent Developments
Table 94. Thermo Fisher ScientificInc. Basic Information
Table 95. Thermo Fisher ScientificInc. Cancer Biopsy Product Overview
Table 96. Thermo Fisher ScientificInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fisher ScientificInc. Business Overview
Table 98. Thermo Fisher ScientificInc. Recent Developments
Table 99. Danaher Basic Information
Table 100. Danaher Cancer Biopsy Product Overview
Table 101. Danaher Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Danaher Business Overview
Table 103. Danaher Recent Developments
Table 104. Lucence Diagnostics Pte. Ltd. Basic Information
Table 105. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Overview
Table 106. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Lucence Diagnostics Pte. Ltd. Business Overview
Table 108. Lucence Diagnostics Pte. Ltd. Recent Developments
Table 109. GRAILInc. Basic Information
Table 110. GRAILInc. Cancer Biopsy Product Overview
Table 111. GRAILInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. GRAILInc. Business Overview
Table 113. GRAILInc. Recent Developments
Table 114. Guardant Health Basic Information
Table 115. Guardant Health Cancer Biopsy Product Overview
Table 116. Guardant Health Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Guardant Health Business Overview
Table 118. Guardant Health Recent Developments
Table 119. Exact Sciences Corporation Basic Information
Table 120. Exact Sciences Corporation Cancer Biopsy Product Overview
Table 121. Exact Sciences Corporation Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Exact Sciences Corporation Business Overview
Table 123. Exact Sciences Corporation Recent Developments
Table 124. Freenome HoldingsInc. Basic Information
Table 125. Freenome HoldingsInc. Cancer Biopsy Product Overview
Table 126. Freenome HoldingsInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Freenome HoldingsInc. Business Overview
Table 128. Freenome HoldingsInc. Recent Developments
Table 129. Oncimmune Basic Information
Table 130. Oncimmune Cancer Biopsy Product Overview
Table 131. Oncimmune Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Oncimmune Business Overview
Table 133. Oncimmune Recent Developments
Table 134. Chronix BiomedicalInc. Basic Information
Table 135. Chronix BiomedicalInc. Cancer Biopsy Product Overview
Table 136. Chronix BiomedicalInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Chronix BiomedicalInc. Business Overview
Table 138. Chronix BiomedicalInc. Recent Developments
Table 139. Personal Genome Diagnostics Inc. Basic Information
Table 140. Personal Genome Diagnostics Inc. Cancer Biopsy Product Overview
Table 141. Personal Genome Diagnostics Inc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Personal Genome Diagnostics Inc. Business Overview
Table 143. Personal Genome Diagnostics Inc. Recent Developments
Table 144. Global Cancer Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 145. Global Cancer Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Cancer Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 147. North America Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Cancer Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 149. Europe Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Cancer Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 151. Asia Pacific Cancer Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Cancer Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 153. South America Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Cancer Biopsy Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Cancer Biopsy Sales Forecast by Type (2026-2033) & (K Units)
Table 157. Global Cancer Biopsy Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Cancer Biopsy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 159. Global Cancer Biopsy Sales (K Units) Forecast by Application (2026-2033)
Table 160. Global Cancer Biopsy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Cancer Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cancer Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cancer Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cancer Biopsy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2024)
Table 10. Global Market Cancer Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cancer Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cancer Biopsy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cancer Biopsy Sales by Type (K Units)
Table 26. Global Cancer Biopsy Market Size by Type (M USD)
Table 27. Global Cancer Biopsy Sales (K Units) by Type (2020-2025)
Table 28. Global Cancer Biopsy Sales Market Share by Type (2020-2025)
Table 29. Global Cancer Biopsy Market Size (M USD) by Type (2020-2025)
Table 30. Global Cancer Biopsy Market Size Share by Type (2020-2025)
Table 31. Global Cancer Biopsy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cancer Biopsy Sales (K Units) by Application
Table 33. Global Cancer Biopsy Market Size by Application
Table 34. Global Cancer Biopsy Sales by Application (2020-2025) & (K Units)
Table 35. Global Cancer Biopsy Sales Market Share by Application (2020-2025)
Table 36. Global Cancer Biopsy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cancer Biopsy Market Share by Application (2020-2025)
Table 38. Global Cancer Biopsy Sales Growth Rate by Application (2020-2025)
Table 39. Global Cancer Biopsy Sales by Region (2020-2025) & (K Units)
Table 40. Global Cancer Biopsy Sales Market Share by Region (2020-2025)
Table 41. Global Cancer Biopsy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cancer Biopsy Market Size Market Share by Region (2020-2025)
Table 43. North America Cancer Biopsy Sales by Country (2020-2025) & (K Units)
Table 44. North America Cancer Biopsy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cancer Biopsy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cancer Biopsy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cancer Biopsy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cancer Biopsy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cancer Biopsy Sales by Country (2020-2025) & (K Units)
Table 50. South America Cancer Biopsy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cancer Biopsy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cancer Biopsy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cancer Biopsy Production (K Units) by Region(2020-2025)
Table 54. Global Cancer Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cancer Biopsy Revenue Market Share by Region (2020-2025)
Table 56. Global Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cancer Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Qiagen N.V. Basic Information
Table 62. Qiagen N.V. Cancer Biopsy Product Overview
Table 63. Qiagen N.V. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Qiagen N.V. Business Overview
Table 65. Qiagen N.V. SWOT Analysis
Table 66. Qiagen N.V. Recent Developments
Table 67. IlluminaInc. Basic Information
Table 68. IlluminaInc. Cancer Biopsy Product Overview
Table 69. IlluminaInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. IlluminaInc. Business Overview
Table 71. IlluminaInc. SWOT Analysis
Table 72. IlluminaInc. Recent Developments
Table 73. ANGLE Plc Basic Information
Table 74. ANGLE Plc Cancer Biopsy Product Overview
Table 75. ANGLE Plc Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. ANGLE Plc Business Overview
Table 77. ANGLE Plc SWOT Analysis
Table 78. ANGLE Plc Recent Developments
Table 79. Myriad Genetics Basic Information
Table 80. Myriad Genetics Cancer Biopsy Product Overview
Table 81. Myriad Genetics Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Myriad Genetics Business Overview
Table 83. Myriad Genetics Recent Developments
Table 84. HologicInc. Basic Information
Table 85. HologicInc. Cancer Biopsy Product Overview
Table 86. HologicInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. HologicInc. Business Overview
Table 88. HologicInc. Recent Developments
Table 89. BioceptInc. Basic Information
Table 90. BioceptInc. Cancer Biopsy Product Overview
Table 91. BioceptInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioceptInc. Business Overview
Table 93. BioceptInc. Recent Developments
Table 94. Thermo Fisher ScientificInc. Basic Information
Table 95. Thermo Fisher ScientificInc. Cancer Biopsy Product Overview
Table 96. Thermo Fisher ScientificInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fisher ScientificInc. Business Overview
Table 98. Thermo Fisher ScientificInc. Recent Developments
Table 99. Danaher Basic Information
Table 100. Danaher Cancer Biopsy Product Overview
Table 101. Danaher Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Danaher Business Overview
Table 103. Danaher Recent Developments
Table 104. Lucence Diagnostics Pte. Ltd. Basic Information
Table 105. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Overview
Table 106. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Lucence Diagnostics Pte. Ltd. Business Overview
Table 108. Lucence Diagnostics Pte. Ltd. Recent Developments
Table 109. GRAILInc. Basic Information
Table 110. GRAILInc. Cancer Biopsy Product Overview
Table 111. GRAILInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. GRAILInc. Business Overview
Table 113. GRAILInc. Recent Developments
Table 114. Guardant Health Basic Information
Table 115. Guardant Health Cancer Biopsy Product Overview
Table 116. Guardant Health Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Guardant Health Business Overview
Table 118. Guardant Health Recent Developments
Table 119. Exact Sciences Corporation Basic Information
Table 120. Exact Sciences Corporation Cancer Biopsy Product Overview
Table 121. Exact Sciences Corporation Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Exact Sciences Corporation Business Overview
Table 123. Exact Sciences Corporation Recent Developments
Table 124. Freenome HoldingsInc. Basic Information
Table 125. Freenome HoldingsInc. Cancer Biopsy Product Overview
Table 126. Freenome HoldingsInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Freenome HoldingsInc. Business Overview
Table 128. Freenome HoldingsInc. Recent Developments
Table 129. Oncimmune Basic Information
Table 130. Oncimmune Cancer Biopsy Product Overview
Table 131. Oncimmune Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Oncimmune Business Overview
Table 133. Oncimmune Recent Developments
Table 134. Chronix BiomedicalInc. Basic Information
Table 135. Chronix BiomedicalInc. Cancer Biopsy Product Overview
Table 136. Chronix BiomedicalInc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Chronix BiomedicalInc. Business Overview
Table 138. Chronix BiomedicalInc. Recent Developments
Table 139. Personal Genome Diagnostics Inc. Basic Information
Table 140. Personal Genome Diagnostics Inc. Cancer Biopsy Product Overview
Table 141. Personal Genome Diagnostics Inc. Cancer Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Personal Genome Diagnostics Inc. Business Overview
Table 143. Personal Genome Diagnostics Inc. Recent Developments
Table 144. Global Cancer Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 145. Global Cancer Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Cancer Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 147. North America Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Cancer Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 149. Europe Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Cancer Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 151. Asia Pacific Cancer Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Cancer Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 153. South America Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Cancer Biopsy Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Cancer Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Cancer Biopsy Sales Forecast by Type (2026-2033) & (K Units)
Table 157. Global Cancer Biopsy Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Cancer Biopsy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 159. Global Cancer Biopsy Sales (K Units) Forecast by Application (2026-2033)
Table 160. Global Cancer Biopsy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cancer Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Biopsy Market Size (M USD), 2024-2033
Figure 5. Global Cancer Biopsy Market Size (M USD) (2020-2033)
Figure 6. Global Cancer Biopsy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Biopsy Product Life Cycle
Figure 13. Cancer Biopsy Sales Share by Manufacturers in 2024
Figure 14. Global Cancer Biopsy Revenue Share by Manufacturers in 2024
Figure 15. Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cancer Biopsy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Biopsy Revenue in 2024
Figure 18. Industry Chain Map of Cancer Biopsy
Figure 19. Global Cancer Biopsy Market PEST Analysis
Figure 20. Global Cancer Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Biopsy Market Share by Type
Figure 27. Sales Market Share of Cancer Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Biopsy by Type in 2024
Figure 29. Market Size Share of Cancer Biopsy by Type (2020-2025)
Figure 30. Market Size Share of Cancer Biopsy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Biopsy Market Share by Application
Figure 33. Global Cancer Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Biopsy Sales Market Share by Application in 2024
Figure 35. Global Cancer Biopsy Market Share by Application (2020-2025)
Figure 36. Global Cancer Biopsy Market Share by Application in 2024
Figure 37. Global Cancer Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Biopsy Market Size Market Share by Region (2020-2025)
Figure 40. North America Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Biopsy Sales Market Share by Country in 2024
Figure 43. North America Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Biopsy Market Size Market Share by Country in 2024
Figure 45. U.S. Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Biopsy Market Size Market Share by Country in 2024
Figure 55. Germany Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Biopsy Market Size Market Share by Region in 2024
Figure 68. China Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Cancer Biopsy Sales Market Share by Country in 2024
Figure 80. South America Cancer Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Biopsy Market Size Market Share by Country in 2024
Figure 82. Brazil Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Biopsy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Biopsy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cancer Biopsy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cancer Biopsy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cancer Biopsy Market Share Forecast by Type (2026-2033)
Figure 111. Global Cancer Biopsy Sales Forecast by Application (2026-2033)
Figure 112. Global Cancer Biopsy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Cancer Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Biopsy Market Size (M USD), 2024-2033
Figure 5. Global Cancer Biopsy Market Size (M USD) (2020-2033)
Figure 6. Global Cancer Biopsy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Biopsy Product Life Cycle
Figure 13. Cancer Biopsy Sales Share by Manufacturers in 2024
Figure 14. Global Cancer Biopsy Revenue Share by Manufacturers in 2024
Figure 15. Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cancer Biopsy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Biopsy Revenue in 2024
Figure 18. Industry Chain Map of Cancer Biopsy
Figure 19. Global Cancer Biopsy Market PEST Analysis
Figure 20. Global Cancer Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Biopsy Market Share by Type
Figure 27. Sales Market Share of Cancer Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Biopsy by Type in 2024
Figure 29. Market Size Share of Cancer Biopsy by Type (2020-2025)
Figure 30. Market Size Share of Cancer Biopsy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Biopsy Market Share by Application
Figure 33. Global Cancer Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Biopsy Sales Market Share by Application in 2024
Figure 35. Global Cancer Biopsy Market Share by Application (2020-2025)
Figure 36. Global Cancer Biopsy Market Share by Application in 2024
Figure 37. Global Cancer Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Biopsy Market Size Market Share by Region (2020-2025)
Figure 40. North America Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Biopsy Sales Market Share by Country in 2024
Figure 43. North America Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Biopsy Market Size Market Share by Country in 2024
Figure 45. U.S. Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Biopsy Market Size Market Share by Country in 2024
Figure 55. Germany Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Biopsy Market Size Market Share by Region in 2024
Figure 68. China Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Cancer Biopsy Sales Market Share by Country in 2024
Figure 80. South America Cancer Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Biopsy Market Size Market Share by Country in 2024
Figure 82. Brazil Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Biopsy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Biopsy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cancer Biopsy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cancer Biopsy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cancer Biopsy Market Share Forecast by Type (2026-2033)
Figure 111. Global Cancer Biopsy Sales Forecast by Application (2026-2033)
Figure 112. Global Cancer Biopsy Market Share Forecast by Application (2026-2033)
